Key Notes About PharmEasy Analysis Over the past six months, PharmEasy’s investors have been forced to make one of two undesirable decisions: accept a level of dilution that would almost wipe out the value of their investment, or give the company more money. Unexpectedly more people than anticipated have chosen the former. Through the rights … Continue reading The ‘down round’ for PharmEasy grows as a result of investor demand